Safety and efficacy of autologous mesenchymal stromal cells transplantation in patients undergoing living donor kidney transplantation: A pilot study

Nephrology

Volumn 20, Issue 1, 2015, Pages 25-33

  Mudrabettu, Chetan ^a   Kumar, Vinod ^a   Rakha, Aruna ^a   Yadav, Ashok K ^a   Ramachandran, Raja ^a   Kanwar, Deepesh B ^a   Nada, Ritambhra ^a   Minz, Mukut ^a   Sakhuja, Vinay ^a   Marwaha, Neelam ^a   Jha, Vivekanand ^a,b  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

^b GEORGE INSTITUTE FOR GLOBAL HEALTH   (Australia)

Author keywords

immunomodulation; mesenchymal stromal cell; renal transplant; T regulatory cell

Indexed keywords

COTRIMOXAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TACROLIMUS; THYMOCYTE ANTIBODY; VALGANCICLOVIR;

ADULT; ARTICLE; AUTOTRANSPLANTATION; CASE REPORT; CD4 LYMPHOCYTE COUNT; CD4+ CD25+ T LYMPHOCYTE; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KIDNEY TRANSPLANTATION; LIVING DONOR; LOW DRUG DOSE; LYMPHOCYTE PROLIFERATION; MALE; MESENCHYME CELL; OUTCOME ASSESSMENT; PATIENT SAFETY; PILOT STUDY; REGULATORY T LYMPHOCYTE; STROMA CELL; YOUNG ADULT; ADVERSE EFFECTS; EVALUATION STUDY; MESENCHYMAL STEM CELL TRANSPLANTATION; T LYMPHOCYTE; TREATMENT OUTCOME;

ADULT; FEMALE; HUMANS; KIDNEY TRANSPLANTATION; LIVING DONORS; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; PILOT PROJECTS; T-LYMPHOCYTES; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 84919742376     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/nep.12338     Document Type: Article

References (26)

1. Taal MW, Chertow GM, Marsden PA, Skorecki K, Yu ASL, Brenner BM, (eds) Brenner's and Rector's The Kidney, 9th edn. Philadelphia, PA: Elsevier Saunders, 2012.
2. Meier-Kriesche HU, Schold JD, Kaplan B,. Long term renal allograft survival: Have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am. J. Transplant. 2004; 4 (8): 1289-1295.
3. Denton MD, Magee CC, Sayegh MH,. Immunosuppressive strategies in transplantation. Lancet 1999; 353: 1083-1091.
4. Bostom AD, Brown RS Jr, Chavers BM, et al. Prevention of posttransplant cardiovascular disease-report and recommendations of an ad hoc group. Am. J. Transplant. 2002; 2: 491-500.
5. Kawai T, Benedict Cosimi A,. Induction of tolerance in clinical kidney transplantation. Clin. Transplant. 2010; 24 (Suppl 22): 2-5.
6. Dahlke MH, Hoogduijn M, Eggenhofer E, et al. Toward MSC in solid organ transplantation: 2008 position paper of the MISOT Study Group. Transplantation 2009; 88: 614-619.
7. Hoogduijn MJ, Popp FC, Grohnert A, et al. Advancement of mesenchymal stem cell therapy in solid organ transplantation (MISOT). Transplantation 2010; 90: 124-126.
8. Perico N, Casiraghi F, Introna M, et al. Autologous mesenchymal stromal cells and kidney transplantation: A pilot study of safety and clinical feasibility. Clin. J. Am. Soc. Nephrol. 2011; 6 (2): 412-422.
9. Tan J, Wu W, Xu X, et al. Induction therapy with autologous mesenchymal stem cells in living related kidney transplants: A randomized controlled trial. JAMA 2012; 307 (11): 1169-1177.
10. Capelli C, Domenghini M, Barleri G, et al. Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts. Bone Marrow Transplant. 2007; 40 (8): 785-791.
11. Liu W, Putnam AL, Xu-Yu Z, et al. CD127 expression inversely correlates with FoxP3 and suppressive function of human CD4+ T reg cells. J. Exp. Med. 2006; 203 (7): 1701-1711.
12. Schulz Zur Wiesch J, Thomssen A, Hartjen P, et al. Comprehensive analysis of frequency and phenotype of T regulatory cells in HIV infection: CD39 expression of FoxP3+ T regulatory cells correlates with progressive disease. J. Virol. 2011; 85 (3): 1287-1297.
13. Ramachandran R, Jha V,. Kidney transplantation is associated with catastrophic out of pocket expenditure in India. PLoS ONE 2013; 8 (7): e67812.
14. Casiraghi F, Azzollini N, Cassis P, et al. Pretransplant infusion of mesenchymal stem cells prolongs the survival of a semiallogeneic heart transplant through the generation of regulatory T cells. J. Immunol. 2008; 181: 3933-3946.
15. Riella L, Chandraker A,. Stem cell therapy in kidney transplantation. JAMA 2012; 308: 130-131.
16. Casiraghi F, Azzollini N, Todeschini M, et al. Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation. Am. J. Transplant. 2012; 12 (9): 2373-2383.
17. Peng Y, Ke M, Xu L, et al. Donor-derived mesenchymal stem cells combined with low-dose tacrolimus prevent acute rejection after renal transplantation: A clinical pilot study. Transplantation 2013; 95 (1): 161-168.
18. François M, Copland IB, Yuan S, Romieu-Mourez R, Waller EK, Galipeau J,. Cryopreserved mesenchymal stromal cells display impaired immunosuppressive properties as a result of heat-shock response and impaired interferon-g licensing. Cytotherapy 2012; 14: 147e52.
19. Krampera M,. Mesenchymal stromal cell 'licensing': A multi- step process. Leukemia 2011; 25: 1408e14.
20. Stagg J, Galipeau J,. Mechanisms of immune modulation by mesenchymal stromal cells and clinical translation. Curr. Mol. Med. 2013; 13 (5): 856-867.
21. Zhukareva V, Obrocka M, Houle JD, Fischer I, Neuhuber B,. Secretion profile of human bone marrow stromal cells: Donor variability and response to inflammatory stimuli. Cytokine 2010; 50: 317e21.
22. Samuelsson H, Ringden O, Lonnies H, Le Blanc K,. Optimizing in vitro conditions for immunomodulation and expansion of mesenchymal stromal cells. Cytotherapy 2009; 11: 129e36.
23. Kuilman T, Peeper DS,. Senescence-messaging secretome: SMS-ing cellular stress. Nat. Rev. Cancer 2009; 9 (2): 81-94.
24. Severino V, Alessio N, Farina A, et al. Insulin-like growth factor binding proteins 4 and 7 released by senescent cells promote premature senescence in mesenchymal stem cells. Cell Death Dis. 2013; 4: e911.
25. Dummer CD, Carpio VN, Gonçalves LF, Manfro RC, Veronese FV,. FOXP3+ regulatory T cells: From suppression of rejection to induction of renal allograft tolerance. Transpl. Immunol. 2012; 26: 1-10.
26. Franquesa M, Baan CC, Korevaar SS, et al. The effect of rabbit antithymocyte globulin on human mesenchymal stem cells. Transpl. Int. 2013; 26 (6): 651-658.